Alnylam Pharmaceuticals
ALNY
#573
Rank
S$47.89 B
Marketcap
$371.31
Share price
-2.11%
Change (1 day)
59.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company